What Does Each Test Actually Measure?

Dry eye is not simply a question of how much water is in your eyes. As we have already seen in this guide, several different systems can be involved:

• •the tear film
• •the meibomian glands
• •aqueous tears
• •the ocular surface
• •the eyelids and blinking
• •inflammation
• •sensory nerves

No single test can examine all of them. Instead, each test gives us one piece of information. The goal is to put those pieces together.

One of the most common dry-eye tests looks at what happens between blinks. After you blink, the tear film spreads across the eye. Ideally, it should remain reasonably stable until you blink again.

Tear breakup time measures how long it takes before the first area of that tear film begins to break apart. There are different ways to measure it, including non-invasive methods and methods that use fluorescein dye.

The important question behind the test is simple: how stable is my tear film between blinks? What it does not automatically tell us is why the tear film is unstable.

TBUT & NIBUT: understanding tear-film stability

Special dyes can reveal areas of the ocular surface that are not completely healthy. The clinician looks at where staining appears and how much is present. This can provide information about ocular-surface damage or disruption.

So the question here is: is the surface of my eye showing signs of stress or damage? But staining does not automatically tell us what caused that damage. The pattern and the rest of the examination matter.

Ocular-Surface Staining: what the dyes can show

The Schirmer test uses a small strip of paper placed near the lower eyelid. The tears wet the paper, and the clinician measures how far the moisture travels.

This test is mainly used to investigate the aqueous part of the tear system. In simple terms, it asks: am I producing enough aqueous tear fluid?

But it does not tell us whether the lipid part of the tear film is working normally. It does not examine the meibomian glands. And it does not tell us whether the tear film is stable between blinks. So a normal Schirmer result does not mean that everything about the tear film is normal.

The Schirmer Test: what it measures — and what it doesn't

If you look closely at the edge of the lower eyelid, there is normally a small reservoir of tears between the eyelid and the eye. This is called the tear meniscus. Its height can be measured, often with imaging technology.

It gives us information about tear volume. The question is: how much tear fluid appears to be available on the ocular surface?

That is related to aqueous tears, but it is not exactly the same question as the Schirmer test. One looks at the tear volume present. The other assesses tear wetting and production under particular test conditions.

Tear Meniscus Height: understanding tear volume

The meibomian glands produce meibum — the lipid-rich material that contributes to the outer part of the tear film. A clinician can gently apply pressure to the eyelid and observe what comes out. This can provide information about how easily the glands express, how much meibum is released, and what that meibum looks like.

The question is: are the glands delivering meibum normally? This tells us about gland function. It is different from looking at gland structure.

Meibomian Gland Expression & Meibum Quality

Meibography creates images of the meibomian glands inside the eyelids. It can show their shape and structure and reveal areas where gland tissue has been lost or altered.

So the question is: what do my meibomian glands look like? That can be valuable information. But there is an important distinction: structure is not the same thing as function. A gland image cannot tell us everything about what the glands are producing today or how well the resulting lipids are functioning in the tear film.

Meibography: what gland images can — and can't — tell you

Some instruments examine the lipid-rich surface of the tear film using patterns created when light reflects from it. Depending on the device, this may provide information about the appearance, distribution or estimated thickness of the lipid layer.

The question is approximately: what does the lipid component of my tear film look like?

But this test also has limitations. As we discussed earlier in this guide, lipid-layer thickness alone does not tell us everything about lipid function. Composition, organization and distribution also matter. So a single lipid-layer number should not be treated as a complete measurement of “tear quality.”

Lipid-Layer Interferometry: what are we actually looking at?

Another test takes a very small sample of tears and measures their osmolarity. In patient language, we can think of this as asking: have my tears become unusually concentrated?

Abnormal concentration can be a sign that the tear-film system has lost its normal balance. Osmolarity is one of the markers used in the current TFOS diagnostic framework. But once again, the result does not tell us the entire mechanism. It tells us something about the state of the tear film, not necessarily why it reached that state.

Tear Osmolarity: what does the number actually mean?

Blinking is easy to overlook because we normally do it without thinking. But a clinician or imaging system can assess things such as how often you blink, whether the blink is complete, and how the eyelids move across the ocular surface.

The question is: is blinking doing its job properly? This can be particularly useful when tear-film instability or exposure is suspected. And importantly, blink assessment looks at something that Schirmer, meibography and osmolarity cannot tell us.

Blink & Eyelid Assessment

The cornea contains a dense network of sensory nerves. Testing corneal sensitivity can help assess how strongly the cornea responds to stimulation.

The question here is different again: is the sensory system of the ocular surface responding normally?

Reduced sensitivity can sometimes accompany significant ocular-surface disease. In other situations, symptoms may be unusually strong relative to routine clinical findings. More specialized nerve assessment may then be considered. But nerve testing must be interpreted carefully and in context.

Corneal Sensitivity & Nerve Testing

Because they answer different questions. You can think of a dry-eye evaluation like this:

• •Tear breakup time → is the tear film stable?
• •Staining → is the ocular surface being affected?
• •Schirmer → what can we learn about aqueous tear production?
• •Tear meniscus → how much tear fluid is present?
• •Gland expression → how are the meibomian glands functioning?
• •Meibography → what do the glands look like structurally?
• •Lipid-layer imaging → what can we observe about the lipid component?
• •Osmolarity → are the tears unusually concentrated?
• •Blink assessment → is blinking functioning normally?
• •Corneal sensitivity → how is the sensory system responding?

None of these questions means exactly the same thing.

A comprehensive dry-eye clinic may have many different instruments available. That does not mean that every person needs every possible measurement.

The tests chosen should depend on the clinical picture and on what the clinician is trying to understand. If the examination suggests an aqueous problem, certain tests become particularly useful. If meibomian gland dysfunction is suspected, other tests become more relevant. If symptoms and routine findings do not fit together, sensory testing may become more important.

Testing should therefore be purposeful, not simply a collection of numbers.

There is one more important point. Some tests can temporarily change the tear film. Eye drops, dyes, touching the ocular surface, bright examination lights or simply preventing normal blinking can influence later measurements.

For this reason, TFOS recommends performing dry-eye tests in a thoughtful order, generally moving from less disruptive tests toward more invasive ones.

This is another reason why two sets of results from different clinics may not always be directly comparable. How a test was performed can matter too.

This is probably the most important idea to carry into the rest of this chapter.

A short breakup time means the tear film became unstable quickly. It does not automatically mean MGD. A low Schirmer result suggests an aqueous problem. It does not explain the entire dry-eye picture. Meibomian gland loss on an image tells us something about gland structure. It does not automatically tell us how severe someone’s symptoms should be. Staining tells us that the ocular surface is affected. It does not automatically tell us why.

Every result needs to be interpreted in context.